CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Cerebros Medical Systems

Cerebros Medical Systems is a Scranton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ontario Public Health Association

Ontario Public Health Association is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioRx

BioRx is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Cincinnati, OH. To find more information about BioRx, please visit www.biorx.net

Darin M. Camarena Health Center

Darin M. Camarena Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Madera, CA. To find more information about Darin M. Camarena Health Center, please visit www.camarenahealth.org

Avatar International

Avatar International is a Lake Mary, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.